Skip to main content
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2019 Jan 28;23(2):1634. doi: 10.1111/jcmm.14142

Corrigendum

PMCID: PMC6349147  PMID: 30690921

In Zhi et al,1 the original article contains errors in Figure 2C. The correct figure is shown below. The authors confirm all results and conclusions of this article remain unchanged.

Figure 2.

Figure 2

IGF2 is the host gene of miR‐483‐3p. A, The mRNA and protein expression levels of IGF2 were lower in HSCR tissues than controls determined by qRT‐PCR and Western blot. B, The 293T and SH‐SY5Y cells were transfected with IGF2 siRNA and then the expression of miR‐483‐3p was reduced in both cell lines. C, Cotransfection of miR‐483‐3p mimics partially rescued the IGF2 siRNA‐mediated decrease in cell migration and proliferation. Absorbance at 450 nm was presented as mean ± SE. *means significant difference *P < 0.05, **P < 0.01, ***< 0.0001

The correct figure has been updated in the online version.

The authors wished to apologize for any misunderstanding or inconvenience this may have caused.

REFERENCE

  • 1. Zhi Z, Zhu H, Lv X, et al. IGF2‐derived miR‐483‐3p associated with Hirschsprung's disease by targeting FHL1. J Cell Mol Med. 2018;22(10):4913‐4921. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES